Lawyers Seeking to Consolidate Wegovy Lawsuits in MDL In December 2023, lawyers asked judges to establish a Multi-District Litigation (MDL) to centralize all Wegovy lawsuits nationwide into a single federal court, under one judge
There is no intake gate to see the number
GLP-1 receptor agonist intolerance refers to a situation where side effects become severe enough that a patient cannot continue treatment comfortably
New Horizons Wellness Center uses advanced body composition machines to track your results accurately
The debate around GLP-1 coverage is a prime example of the balancing act benefits leaders face as they navigate skyrocketing demand, affordability concerns, and uncertainty around long-term patient outcomes. Just last week, Cigna confirmed it was no longer covering GLP-1 weight loss drugs for its own employees effective July 1
Biochemical control of bone loss and stone-forming propensity by potassium-calcium citrate after bariatric surgery